On August 4, Aptiv PLC fell 10.9% in pre-market trading, trading at $51.4/share, with turnover of approximately $1.64 million. The decline was triggered by the company's Q2 earnings release, which included a substantial downward revision to full-year guidance.

While Aptiv's Q2 adjusted EPS of $1.63 beat the consensus estimate of $1.42-$1.43, representing a 24.4% year-over-year increase from $1.31, net sales of $3.27 billion missed expectations of $3.31 billion. More critically, the company slashed its full-year outlook: adjusted EPS guidance was lowered to $5.60-$5.80 from the prior range of $5.70-$6.10, well below the analyst consensus of $5.91. Full-year net sales expectations were reduced to $12.60-$12.80 billion from $12.80-$13.20 billion, significantly trailing the Street estimate of $13.27 billion. Third-quarter guidance was equally disappointing, with projected adjusted EPS of $1.25-$1.35 falling far short of the $1.60 consensus, while revenue guidance of $3.12-$3.22 billion also missed the $3.30 billion estimate.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)